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Abstract
Objectives—Health valuation studies enhance economic evaluations of treatments by estimating 
the value of health-related quality of life (HRQoL). The Patient-Reported Outcomes Measurement 
Information System® (PROMIS) includes a 29-item short-form HRQOL measure, the 
PROMIS-29.
Methods—To value PROMIS-29 responses on a quality-adjusted life year (QALY) scale, we 
conducted a national survey (N=7557) using quota sampling based on the US 2010 Census. Based 
on 541 paired comparisons with over 350 responses each, pair-specific probabilities were 
incorporated into a weighted least-squared estimator.
Results—All losses in HRQoL influenced choice; however, respondents valued losses in 
physical function, anxiety, depression, sleep, and pain more than those in fatigue and social 
functioning.
Conclusions—This paper introduces a novel approach to valuing HRQoL for economic 
evaluations using paired comparisons and provides a tool to translate PROMIS-29 responses into 
QALYs.
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To inform resource allocation decisions and patient guidelines, comparative effectiveness 
research (CER) aims to “provide evidence on the effectiveness, benefits, and harms of 
different treatment options” including the differences in health outcomes.(1) Other events 
may coincide with health outcomes, such as economic (e.g., cost), clinical (e.g., disease), 
and humanistic outcomes (e.g., privacy).(2) However, this study solely focuses on 
enhancing the measurement and valuation of health outcomes for CER.
All measures of health outcomes record duration (e.g., In the past 7 days, I felt depressed). 
Although health status (e.g., Do you currently feel depressed?) may be useful to diagnose a 
disease, formulate a prognosis, or indirectly capture health outcomes, health status does not 
quantify the burden of an outcome without further information. Continuing the example for 
CER, the likelihood of reporting current depression may be different between two 
interventions, but this prevalence information may not be decision-relevant unless the 
duration and frequency of depressive symptoms can be taken into account.
Due to its chronologic reference, outcomes evidence is more informative than health status 
evidence, yet outcomes evidence alone may be not sufficient to inform decisions, 
particularly when alternative treatments have distinct advantages. To resolve such dilemmas, 
an understanding of outcome value is required (i.e., preference-based weights or tariffs). 
Discrete choice experiments (DCEs) enhance our understanding of health outcomes by 
asking respondents to choose between alternatives (e.g., 1 week of depression vs. 1 week of 
pain). Such choices define the relative value of treatment outcomes and facilitate treatment 
recommendations. This study expresses the value of health outcomes along a common 
metric for CER, namely quality-adjusted life years (QALYs).
Among health outcomes, a QALY represents a year with no health problems and serves as 
the fundamental unit of measurement in outcomes research. All other health outcomes 
represent a loss in health-related quality of life (HRQoL) from this standard, inherently 
reducing a person’s quality-adjusted life. Valuation studies, like this one, are typically 
designed to identify the value of outcomes in terms of lost QALYs (e.g., a year feeling 
sometimes depressed equals a loss of 0.26 QALYs). The debate over this numéraire began 
with its introduction in 1970(3) and remains heated,(4) particularly in the United States.(5) 
Nevertheless, no other numéraire has achieved comparable notoriety in the summary of 
health outcomes, such as patient-reported outcomes (PRO) measures.
The Patient-Reported Outcomes Measurement Information System® (PROMIS) includes 
publicly available generic profile HRQoL measures.(6) These standardized PRO measures 
complement clinical findings on patient health (e.g., blood pressure) and epidemiologic 
evidence in the community setting (e.g., viral infection rates) for CER. The PROMIS 
measures provide scores for multiple HRQoL domains; however, they do not summarize 
outcomes across domains. By incorporating DCE evidence, health valuation studies 
summarize outcomes across domains by weighing losses in HRQoL in terms of their 
influence on choice. In addition, such preference elicitation tasks can ask respondents about 
the tradeoff between losses in HRQoL and lifespan. For example, the paired comparison in 
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Figure 1 involves a tradeoff between 10 years sometimes depressed and a loss of 1 QALY. 
Using responses to 541 pairs like this one, this study directly estimate the value of PROMIS 
outcomes on a QALY scale.
Using a dataset with both PROMIS scores and EQ-5D responses, Revicki et al. derived 
regression equations that mapped PROMIS scores to QALYs.(7) This indirect approach is 
analogous to predicting the value of a house from past sales in the neighborhood. No study 
has directly elicited preferences for any PROMIS outcomes to derive values on a QALY 
scale. Furthermore, most health valuation studies focus on instruments that have 1 item per 
domain (e.g., EQ-5D) or that reduce evidence from multiple items to 1 attribute per domain 
(e.g., SF-6D). The use of 1 attribute per domain simplifies the valuation task, but this 
reduction sacrifices the psychometric advantage of improving measurement reliability.(8) 
Ideally, a health valuation study will directly assess preferences (i.e., no mapping) and 
summarize all measured outcomes (i.e., no reduction). To exemplify this, this study values 
the entirety of the PROMIS-29, which includes 4 items on 7 domains as well as an 11-level 
Pain Intensity scale. Never before has such a large instrument been valued.
Aside from being the first to value the PROMIS-29, this is the first national study that uses 
online DCE for health valuation. Previously, Bansback and colleagues conducted an online 
DCE to value the EQ-5D responses by recruiting from the IPSOS Canadian panel, but 
excluded French-speaking Canadians (e.g., Québécois).(9) Craig and colleagues recruited 
members of the Toluna United States panel to value SF-12v1 and SF-6D responses, but this 
national sample was heavily skewed toward older White women.(10) Viney and colleagues 
used an online best-worst scaling task (including death and a survival attribute) to value the 
EQ-5D from the perspective of the Australian general population.(11)The objective of this 
project was to estimate values for 10-year losses in HRQoL on a QALY scale described by 
the PROMIS-29, based on the perspective of adult members of the US population.
Given the extent of study details and the need to limit paper length, we provide a didactic 
appendix that reviews terminology in paired comparisons for health valuation, adjectival 
statements, pair selection (with all results) and an overview of econometric concepts. In 
complement to this appendix, we also provide STATA code, log, and data to allow 
reproducibility of the results within this paper.
METHODS
Theory Underlying Health Outcomes and Choice
A health episode is a description of HRQoL over a period of time and typically includes 
many health-related events (e.g., child birth) and outcomes (e.g., 1 week feeling sometimes 
depressed). The episodic random utility model (ERUM) was introduced in 2008 to describe 
the relationship between health episodes and individual choices, particularly ranking tasks.
(12) ERUM specifies that the utility of a health episode is a function of the health-related 
quality and quantity of life with an additive error term, U(h,t) + ε where h is HRQoL and t is 
duration (t>0). The probability of a choice between two independent episodes, A and B, 
depends on individual understanding of HRQoL domains and durations and may vary due to 
intrapersonal variability or respondent heterogeneity.(9, 12, 13) Alternatively, some studies, 
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particularly those based on time trade-off (TTO) tasks, have applied the instant random 
utility model (IRUM), which first divides HRQoL by duration before including an additive 
error term (U(h/t) + ε), simplifying episodes to health states (i.e., an instantaneous 
experience, h/t). IRUM describes the relationship between health states and choices and 
becomes unstable when duration becomes small (e.g., t → 0).(12, 14)
While the concepts are sometimes used interchangeably,(15) this paper differentiates 
between value and utility. Value refers to a preference-based measure representing the 
choices of a group of individuals, V, and utility is a random latent trait at the individual 
level, which governs a person’s choice (i.e., ERUM). The two concepts are linked, because 
value is inferred from the choices from multiple individuals. Specifically, episodes A and B 
have the same value (VA=VB) if and only if exactly half choose A instead of B (i.e., 
switching A and B has no effect on the aggregate’s choice probability).
In Figure 1, respondents were asked to choose between 10 years sometimes depressed 
followed by death and fewer years with “no health problems” followed by death. As shown 
in Figure 2 (i.e., where the starred line crosses the 50% mark), the probability reaches 50% 
at around 2.6 years (i.e., V(sometimes depressed,10 years)=V(no health problems, 7.4 
years)). This 50% point implies that the loss in HRQoL (sometimes depressed for 10 years) 
equals a loss of 2.6 QALYs. When more or less respondents choose A instead of B, this 
imbalance implies the extent of difference in value.
Application of DCE in Health Valuation
For the purposes of this study, all values are expressed on a QALY scale. Differences in 
QALYs are directly linked to choice probabilities using a cumulative density function 
(CDF): knowing a difference in QALYs predicts the choice probability, and knowing a 
choice probability predicts the difference in QALYs.
Continuing the example, Figure 1 includes a loss in HRQoL (dA=sometimes depressed for 
10 years) and a loss in lifespan (dB=1 QALYs). Suppose you want to predict the choice 
probability in Figure 1 using the QALY results in Figure 2 and the CDF = dB / (dA + dB), 
where dh is the decrement in value associated with the alternative, h. According to Figure 2, 
sometimes depressed for 10 years equals a loss of 2.6 QALYs. Therefore, placing this result 
in the CDF predicts that 27% prefer feeling sometimes depressed over losing 1 QALY (i.e., 
1/(2.6+1)). Looking at the empirical data (Figure 2), the sample probability for this pair is 
actually 28%. Likewise, knowing a sample probability predicts the difference in QALYs. If 
the sample probability in Figure 1 is 28%, we can solve for dA (i.e., 1/(dA+1) =28% or dA = 
2.57 QALYs). The next, more challenging task is to combine evidence from multiple pairs.
All losses in HRQoL can be expressed as decrements in value on a QALY scale, dh, using a 
multi-attribute utility (MAU) regression. By definition, each decrement, dh, decreases the 
likelihood of choosing a particular health episode; however, its effect on choice is non-
additive, depending instead on a CDF (e.g., dB / (dA + dB)). For this study, we assumed that 
choice depends solely on the differential attributes between A and B (dA and dB), not on the 
attributes that they share (i.e., “pivot” or “scope”; see Appendix). Building from this 
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theoretical framework, this study was designed to estimate the independent values of the 
losses in HRQoL captured by the PROMIS-29 on a QALY scale.
Health Outcomes
The PROMIS-29 is quickly becoming a standard for PRO research and practice and 
recommended for initial outcome assessment.(16, 17) Studies continue to support its 
construct validity and feasibility;(18, 19) in fact, one study stated that it may be superior to 
the SF-36.(18) The PROMIS-29 includes seven HRQoL domains (Physical Functioning, 
Anxiety, Depression, Fatigue, Sleep Disturbance, Social Functioning, and Pain), and the 
pain domain has two subdomains (interference and intensity). Each of the 7 domains has 
four 5-level items (i.e., 16 decrements each). In addition to these items, pain intensity is 
assessed using a single 11-point numeric rating scale anchored between no pain (0) and 
worse imaginable pain (10), adding 10 additional decrements.(20) For use in DCE, PROMIS 
responses (e.g., sometimes depressed) were expressed as losses in HRQoL lasting 10 years 
followed by death and parameterized as 122 decrements in value on a QALY scale (i.e., 
(7×16)+10).
Survey Panels
This project recruited US respondents from multiple panel vendors, with each panel 
recruiting 1000 respondents with completed surveys.(21) We chose to employ multiple 
vendors in order to assess and compare costs, services, responsiveness, and quality of data. 
We separated survey hosting from recruitment activities to utilize multiple panels and to 
mitigate potential conflicts of interest. In an effort to maintain control over data quality, no 
panel vendor was allowed to host the survey; therefore, vendors were not able to invite 
respondents based on survey responses or alter or auto-generate responses. A single hosting 
company was used for all respondents, regardless of panel. All study procedures were 
approved by the University of South Florida Institutional Review Board (IRB # 
Pro00000076) and are described in greater detail in a report posted online and in the 
Appendix.(8)
Each panel company sent its members a generic e-mail invitation containing payment 
information and a member-specific hyperlink that provided immediate access to the survey 
informed consent page. Once a respondent clicked on the link, the member-specific data 
(e.g., birth date) were “passed through” and captured by the survey software in order to 
compare these demographic data with survey responses.
Survey Design
Pre-testing at Moffitt Cancer Center and the University of South Florida, as well as pilot 
work in health valuation using online DCEs, verified the feasibility and methodological 
approach for the study.(8, 22) Furthermore, these preliminary studies enabled understanding 
of the issues surrounding task complexity and the appropriateness of the attribute/levels.
(23-25) After the consent page, respondents completed the screener, health, DCE, and 
follow-up components of the survey. Respondents were not allowed to proceed to the next 
page unless all questions on a page were answered. In the screener component, consenting 
respondents were asked 10 questions about their demographic, geographic, and 
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socioeconomic characteristics. If a respondent belonged to a filled demographic quota or 
met any of the four termination criteria (invalid country or state; discordant demographic 
responses; use of a proxy server; JavaScript disabled), he or she was disqualified from 
further participation.
The valuation of health outcomes requires an experimental design that accounts for the 
natural complexity of health and cognitive considerations of subjects. In this study, value 
was quantified by the likelihood of preference and was estimated using choice data on stated 
preferences over health outcomes. The health component included 49 questions derived 
from PROMIS items, which were modified and used with permission of the PROMIS 
Health Organization and the PROMIS Cooperative Group.(26, 27) To reduce response error, 
direction of health was fixed; best health was always placed on the left-hand side of the 
page.(28, 29) After a brief introduction of 3 paired comparisons, the DCE component 
consisted of 30 paired comparisons distributed over 4 sections.(10, 30)
The primary difference between the four DCE sections was their pivots. A pivot is the set of 
the attributes in common for both alternatives in a pair (a.k.a. holdouts).(10, 31) Within a 
DCE section, each pair had the same pivot, which was modified by adding two 
compensating attributes.(30) For the 6 lifespan, the pivot was 10 years with no health 
problems followed by death (see Appendix, Figure 1). For the 8 health pairs in the next 3 
sections, the pivot was 10 years in Good, Fair, and Poor health followed by death, 
respectively (see Appendix). The duration of 10 years is conventionally used in TTO tasks 
as a compromise between avoiding proximal mortality (i.e., not too soon) and promoting 
realism for older respondents whose life expectancy may not exceed 10 years (e.g., age 
100). A loading animation required that at least 8 seconds be spent on each comparison to 
assure sufficient time for page loading and to force respondents to spend a minimum 
duration on each page.
The follow-up component included 33 health, socioeconomic, and survey feedback 
questions and an open-text box for comments. Aside from dropping out of the survey (e.g., 
losing internet connection), respondents were terminated if JavaScript failed or if 2 or more 
hours passed since entry.
Pair Selection and Assignment
Each respondent in a panel was randomly assigned 1 of 1000 unique sequences of lifespan 
pairs and 24 health pairs based on his/her demographic characteristics (reported in survey 
and verified by vendor) to guarantee that each pair-specific sample corresponded to 
demographic quotas.(8)
The 6 lifespan pairs directed respondents to choose between episodes with either reduced 
lifespan or 1 of 6 “health problems” for 10 years, including 3 levels of depression (rarely, 
sometimes, or often feeling worthless, helpless, depressed, and hopeless) and 3 levels of 
mild pain (1, 2, or 3 on a pain scale from 0 [no pain] to 10 [worst pain imaginable]). 
Assigned in random sequence, these problems were selected to be severe enough to be worth 
a loss of lifespan (with “no health problems”), yet mild enough to not imply problems on 
other HRQoL domains. Each problem was compared to 10 losses in lifespan creating 60 
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pairs with 100 responses for each pair from each panel (1000 respondents × 6 responses/60 
pairs=100 responses per pair), except for the third pain intensity level, which was compared 
to 11 losses in lifespan due to a coding error (Figure 2 and Appendix).
Assigned in random sequence, attribute order, and horizontal arrangement, the 24 health 
pairs were taken from a set of 256 item pairs and 224 domain pairs (see Appendix). Each 
item pair directs respondents to choose between a decrement in 1 item and a decrement in 
another item within the same domain (e.g., rarely hopeless vs. rarely helpless). Domain pairs 
trade a decrement in all items in 1 domain (e.g., Depression) for a compensating decrement 
in all items for another domain (e.g., Fatigue). The domain pairs inform the value of the 
domain decrements, and the item pairs allocate this value across the specific items within the 
domain. Under this approach, the addition of items to a domain has no impact on the value 
of the domain (i.e., no double counting). In this design, each of the 480 health pairs (i.e., 256 
item and 224 domain pairs) has 50 responses per panel (1000 respondents × 24 
responses/480 pairs=50 responses per pair; see Appendix for more details on pair selection).
Econometrics
Each of the 226,710 DCE responses (N=7,557 respondents × 30 responses) was 
incorporated into the calculation of the 541 pair-specific probabilities, p1…p541 (i.e., 61 
lifespan and 480 health pairs). Given that we attempted to select pairs with population 
probabilities between 0.1 and 0.9 and pair samples were large (over 350 responses per pair), 
each sample probability is approximately normally distributed with standard error, σ = sqrt(p 
× (1-p) /n).(32, 33). Specifically, the standard error of each sample probability ranges from 
0.016 to 0.026.
To estimate the 122 decrements in the MAU regression, dh, we minimized the sum of 
squared error surrounding these sample probabilities,  , where 
P(.) is a CDF. Two specifications of P(.) were tested: ln(P/(1-P)) = θ(dB -dA) and ln(P/(1-P)) 
= ln(θdB)-ln(θdA). The former specification is a logit model with a rescaling parameter, θ, 
and the latter is a relativity model, P=dB/(dA+dB), which has the advantage that θ factors 
out. These two specifications are compared based on their ability to predict the pair-specific 
probabilities in terms of least squared error (see STATA data, code, and log). Confidence 
intervals are estimated by percentile bootstrap with pair stratification and 1000 resampling 
iterations.
RESULTS
Between March 2012 and July 2012, we recruited 29,031 respondents across the 50 States 
and Washington, DC. Among the 29% who met the survey requirements (e.g., respondents 
were excluded once quotas were filled), 90% completed the survey with a median duration 
of 20 minutes (interquartile range of 16-28 minutes). Compared to the 90% who completed 
the online survey, the 10% with incomplete responses were younger, less educated, and 
more likely to be Black/African American (Table 1). Respondent characteristics in the 
analytic sample were largely similar to the 2010 Census, except for higher educational 
attainment.(34) Even though we did not use geographic quotas, the analytic sample includes 
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respondents from all 50 states and their proportions largely agreed with the 2010 US Census 
(Lin concordance 0.97). Across the 541 pairs, the differences between the weighted and 
unweighted probabilities were small (<0.004); therefore, only the unweighted results are 
shown. Compared to the relativity specification, the logit produced greater squared error 
(6519 vs. 2403) and more negative decrements (36 vs. 0); therefore, all results shown are 
based on the relativity specification.
Tables 2 and 3 provide the MAU estimates, including 122 decrements (i.e., decreases in 
QALYs attributable to losses in HRQoL over 10 years) and their confidence intervals. These 
decrements are non-negative and largely increase from best to worst, suggesting decrement 
acceleration. Figure 3 summarizes these decrements in terms of domain values (i.e., sum of 
all decrements within a domain). For Fatigue, Sleep, and Social Functioning, a shift from 
Level 1 (best) to Level 5 (worst) is less than 10 QALYs; however, such shifts in Physical 
Functioning, Anxiety, Depression, and Pain (interference and intensity) were largely 
considered worse than 10 QALYs.
The value of 10-year losses in HRQOL on a QALY scale can be calculated by adding 
together the 10-year decrements for the PROMIS-29 responses. For example, the mildest 
loss is no problems on all items, except “pain interferes a little bit with work around the 
home” (a decrement of 0.06 QALYs over 10 years). If we assume constant proportionality 
in time (with no health problems and with health problems) as well as no discounting, this 
mildest loss for 1 year has a value of 0.006 QALYs (0.06/10 years or 2.2 quality-adjusted 
days). In other words, such a year has a QALY value of 0.994 (1-0.006). On the contrary, 10 
years with the worst responses on all items (i.e., pits) equals the sum of all 122 10-year 
decrements (94.58 QALYs). Under the same constant proportionality and no discounting 
assumptions, 1 year in pits represents a reduction from full health of 9.458 QALY (i.e., 
−8.458 QALYs; 1-94.58/10). Therefore, the range of 1-year values based on the 
PROMIS-29 is from 1 to −8.458 QALY.
To illustrate the distribution of 1-year values, we applied the 10-year decrements to 
PROMIS-29 responses from the health component of the survey and assumed constant 
proportionality and no discounting to produce the 1-year estimates. The colors indicate the 
distribution by self-reported general health: Excellent, Very Good, Good, Fair and Poor. It is 
important to note that the health component of the survey describes health for a week (not 1 
year) and included “chores” as the 4th pain interference item, not “your enjoyment of life.” 
For illustrative purposes, the responses are assumed to be the same (excluding or including 
this 4th item had no noticeable effect on Figure 4). Figure 4 also shows the mean, standard 
deviation, percent positive, median, and interquartile range. Clearly, the overall distribution 
is skewed with 28.2% below 0 and 10.6% below −1. Among those in fair and poor health, 
31.6% and 74.0% are below −1, respectively.
DISCUSSION
This is the first study to directly value health outcomes based on the PROMIS measures. 
The PROMIS initiative has advanced the science of PRO measurement through instrument 
development using both qualitative and quantitative methods and application of modern 
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measurement theory methods. This study incorporated general US society perspectives using 
DCE methods to value multiple items within seven HRQoL domains of the PROMIS-29. On 
a QALY scale, respondent values suggest that physical function, anxiety, depression, sleep, 
and pain are more detrimental than fatigue and social functioning. In most cases, the worst 
decrement in each item was greater than all other decrements combined, emphasizing the 
importance of measuring poor health over good health.
While interview-based tasks (e.g., TTO) remain commonplace in health valuation, these 
tasks include an adaptive DCE process ending in a statement of indifference.(35) DCEs 
without adaption were applied in this study as an attempt build from valuation studies in 
other fields (e.g., conjoint analysis) and to measure health preferences in the community 
using the internet.
The approach to valuing multiple items per domain undertaken in this study provides an 
alternative to the development of HRQoL instruments specifically for health valuation, such 
as the Health Utilities Index Mark 3 (HUI-3),(36) EQ-5D,(37) and the Quality of Well-
Being-Self Administered (QWB-SA) questionnaire.(38) The PROMIS-29 also differs from 
these preference-based instruments in conceptual framework and health domains covered. 
Although these instruments share a comparable construct of overall health cross-sectionally,
(39) their variability in coverage likely influences their QALY predictions. (40, 41)
The multiple items per domain and calibration to the larger domain item banks create the 
possibility of incorporating more advanced psychometric scores directly into the MUA 
regression of the health valuation study. Score shifts may represent changes in the latent 
domain as a whole, and decrements of each item may represent the parts. Like incorporating 
interaction terms in the MUA, estimation with both score shifts and decrements may test 
whether the whole is greater than the parts.
The relationship between QALYs derived here for the PROMIS-29 and those of existing 
preference-based measures is unknown. More work is needed to demonstrate the advantages 
for CER of the potential improvements in measurement reliability and greater number of 
domains. For example, the EQ-5D includes mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression, while the PROMIS-29 also includes a broader 
assessment of physical function, social function, sleep disturbance, and fatigue. In contrast, 
the HUI-3 takes a different perspective and includes attributes of vision, hearing, speaking, 
ambulation, dexterity, emotion, cognition, and pain. Confounding between domains may 
also cause double counting (e.g., sleep and fatigue) in health valuation, similar to the use of 
multiple correlated items within a domain. In this study, such confounding was controlled 
through the use of domain pairs: comparing bundles of attributes between domains so that 
the number attributes within the domains has no effect on the estimates.(42)
This study focused on valuing 10-year PROMIS-29 outcomes using online DCE and panels 
of US adults. All decrements in health lasted 10 years, a conventional duration used for TTO 
tasks; future studies should examine shorter and longer durations, as research suggests the 
respondent’s age and duration of time horizon systematically impact valuations.(40, 43, 44) 
Great care was taken to verify the respondent qualifications as US adults (e.g., verifying 
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pass-through data, IP geolocation, and concordance of age/birth date responses), and we 
applied quotas at the pair-level to assure demographic representation of each pair-specific 
probability. However, unobservable characteristics concerning participation in panels may 
introduce biases, similar to other recruitment methods including random digit dialing, door-
to-door interviewing, and postal invitations. In this study, we observed selection toward 
higher educated respondents compared to the US Census (Table 1).(34) Still, it is unclear 
whether these potential selection issues introduced bias in the decrement estimates (e.g., Is 
education related to pain preferences?). Future valuation studies may examine additional 
PROMIS items or domains; nevertheless, this study establishes a methodological foundation 
to examine expeditiously US health preferences and may be adapted to explore new 
populations, durations, and items.
The valuation results from this study have implications for the use of PROMIS for CER. In 
addition to identifying the effectiveness and costs of treatments and procedures in practice as 
opposed to clinical trials, CER can be used to ascertain whether the treatments and 
procedures are worth the expense. To achieve this goal, researchers and policymakers need 
to understand the value that people place on the health outcomes. Consistent with previous 
research, extreme forms of depression, anxiety and physical functioning are ranked as highly 
detrimental episodes of health.(45, 46) Likewise, social functioning and mild outcomes (e.g., 
walking up and down stairs) are less important compared to other domains and levels. The 
evidence from this study is a step toward developing a systematic way for researchers to 
assess the effectiveness of alternative interventions based on the value gained from 
improved health outcomes as assessed by PROMIS measures. This will greatly enhance our 
understanding of the relative merit of treatments.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Example of Paired Comparison
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Proportion who prefer a loss in lifespan over pain or depression for 10 years.*
* Pain Intensity was measured on an 11-point scale from no pain (0) to worst imaginable 
pain (10). Each point represents a pair-specific sample and sample sizes range from 711 to 
772, except the first and last pairs on Pain Intensity 3 (571 and 282, respectively) due to a 
coding error.
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Losses in QALYs associated with health problems for 10 years described by PROMIS-29*
QALY=quality-adjusted life year
*Cut points in the bars represent the losses in QALYs associated with an increase in severity 
of a health problem (i.e., Level 1 to 2…Level 10 to 11). The full bar represents the loss in 
QALYs associated with 10 years with the health problem at its worst level of severity.
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Histogram of 1-year values on a quality-adjusted life year scale by self-reported general 
health
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Table 1















 18 to 34 30.05 (116) 30.92 (141) 28.12 (2125) 0.006 30.58
 35 to 54 39.12 (151) 40.57 (185) 35.87 (2711) 36.70
 55 and older 30.83 (119) 28.51 (130) 36.01 (2721) 32.72
Sex
 Male 46.11 (178) 46.71 (213) 48.39 (3657) 0.552 48.53
 Female 53.89 (208) 53.29 (243) 51.61 (3900) 51.47
Race
 White 77.33 (290) 78.83 (350) 84.47 (6195) <0.001 74.66
 Black or African American 20.8 (78) 18.47 (82) 12.09 (887) 11.97
 American Indian or Alaska Native 0.27 (1) 0.45 (2) 0.72 (53) 0.87
 Asian 1.07 (4) 1.58 (7) 2.25 (165) 4.87
 Native Hawaiian or other Pacific Islander 0.53 (2) 0.68 (3) 0.46 (34) 0.16
 Some other race - - - 5.39
 Two or more races 2.93 (11) 2.70 (12) 3.04 (223) 2.06
Hispanic ethnicity
 Hispanic or Latino 13.21 (51) 13.16 (60) 12.86 (972) 0.966 14.22
 Not Hispanic or Latino 86.79 (335) 86.84 (396) 87.14 (6585) 85.78
Educational attainment among age 25 or older
 Less than high school 1.94 (7) 4.52 (19) 1.64 (115) <0.001 14.42
 High school graduate 19.11 (69) 22.86 (96) 17.83 (1252) 28.50
 Some college, no degree 23.82 (86) 23.57 (99) 25.76 (1809) 21.28
 Associate’s degree 17.17 (62) 12.38 (52) 13.03 (915) 7.61
 Bachelor’s degree 34.90 (126) 33.33 (140) 37.83 (2657) 17.74
 Graduate or professional degree 2.77 (10) 3.10 (13) 3.86 (271) 10.44
 Refused/Don’t know 0.28 (1) 0.24 (1) 0.06 (4) -
Household income
 $14,999 or less 11.92 (46) 11.40 (52) 8.55 (646) 0.036 13.46
 $15,000 to $24,999 11.14 (43) 13.38 (61) 10.80 (816) 11.49
 $25,000 to $34,999 12.95 (50) 12.94 (59) 11.75 (888) 10.76
 $35,000 to $49,999 13.73 (53) 14.69 (67) 16.75 (1266) 14.24
 $50,000 to $74,999 22.28 (86) 17.54 (80) 19.88 (1502) 18.28
 $75,000 to $99,999 11.4 (44) 10.75 (49) 11.98 (905) 11.81
 $100,000 to $149,999 6.22 (24) 8.11 (37) 10.27 (776) 11.82
 $150,000 or more 3.89 (15) 4.17 (19) 4.39 (332) 8.14
 Refused/Don’t know 6.48 (25) 7.02 (32) 5.64 (426) -
*
Age, sex, race, and ethnicity estimates for the US are based on 2010 Census Summary File 1.
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Educational attainment and household income are based on 2010 American Community Survey 1-Year Estimates. Unlike the US Census, the 
American Community Survey excluded adults not in the community (e.g., institutionalized) and describes income by the proportion of households, 
not adults.
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Table 3
Valuation of the PROMIS-29: Pain Intensity from No Pain (0) to Worst Pain Imaginable (10)
Loss in QALYs associated with
pain intensity for 10 years dh
* 95% CI
Level 0 to 1 0.23 0.21 0.25
Level 1 to 2 0.21 0.19 0.23
Level 2 to 3 0.28 0.25 0.31
Level 3 to 4 0.53 0.41 0.67
Level 4 to 5 0.80 0.72 0.89
Level 5 to 6 0.80 0.70 0.90
Level 6 to 7 1.07 0.95 1.21
Level 7 to 8 1.69 1.52 1.89
Level 8 to 9 2.61 2.37 2.91
Level 9 to 10 4.10 3.56 4.81
QALY=quality-adjusted life year; dh=decrement CI=confidence interval.
*
Same results as last column in Figure 3.
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